China SXT Pharmaceuticals, Inc. Ordinary Shares
Compare this stock
SXTC Stock Report Card
$
39%
Performance
Score:
10/100
SXTC returned -87.22% in the last 12 months. Based on SPY's performance of -11.50%, its performance is below average giving it a score of 10 of 100.
Technicals
Score:
21/100
SXTC receives a 21 of 100 based on 14 indicators. 2 are bullish, 10 are bearish.
Profit
Score:
63/100
Out of the last 8 quarters, SXTC has had 7 profitable quarters and has increased their profits year over year on 2 of them.
Volatility
Score:
40/100
SXTC has had a lower than average amount of volatility over the last 12 months giving it a score of 40 of 100.
China SXT Pharmaceuticals, Inc. Ordinary Shares Summary
Nasdaq / SXTC
Healthcare
Drug Manufacturers - Specialty & Generic
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
SXTC scored poorly on our reportcard. Here are some similar companies and how they performed.
